Iofina PLC

Iofina PLC maintains a conservative capital structure with a debt-to-equity ratio of 0.12, indicating a low reliance on debt financing. The company's liquidity position is characterized as medium risk, with operating cash flow of $11.03 million and capital expenditures of -$8.38 million, suggesting ongoing investment in operations. However, the risk assessment notes that net cash is negative after subtracting total debt, signaling potential liquidity constraints. Profitability metrics for Iofina are not explicitly provided, but the company's focus on iodine extraction and specialty chemicals aligns with industry preferences for high-margin, niche chemical production. The company's operating cash flow of $11.03 million suggests a positive cash-generating ability, though the extent of profitability relative to industry medians is not quantified. Iofina's revenue is derived from iodine extraction and the production of specialty chemicals, with a focus on North America. The company's geographic exposure is not detailed, but its operations are centered on the United States through its subsidiaries, Iofina Resources, Inc. and Iofina Chemical, Inc.. The company's revenue concentration in a single region may expose it to regional economic and regulatory risks. The company's growth trajectory is not explicitly outlined in the financial data, but the capital expenditures of -$8.38 million suggest ongoing investment in plant and equipment. Analysts have provided a mean price target of $60.00, with a single "buy" recommendation and no "strong buy" ratings, indicating a cautious outlook. Risk factors for Iofina include medium liquidity risk and low dilution risk. The company's debt-to-equity ratio of 0.12 suggests a conservative capital structure, but the negative net cash position after debt is a concern. No dilution sources are explicitly identified in the data, and the dilution risk is assessed as low. Recent events and filings are not detailed in the provided data, but the company's focus on iodine extraction and specialty chemicals suggests exposure to commodity price fluctuations and regulatory changes in the chemical industry.